Cargando…
RETRACTED ARTICLE: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression
BACKGROUND: Aerobic glycolysis is a hallmark of metabolic reprogramming that contributes to tumor progression. However, the mechanisms regulating expression of glycolytic genes in neuroblastoma (NB), the most common extracranial solid tumor in childhood, still remain elusive. METHODS: Crucial transc...
Autores principales: | Song, Huajie, Li, Dan, Wang, Xiaojing, Fang, Erhu, Yang, Feng, Hu, Anpei, Wang, Jianqun, Guo, Yanhua, Liu, Yang, Li, Hongjun, Chen, Yajun, Huang, Kai, Zheng, Liduan, Tong, Qiangsong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098112/ https://www.ncbi.nlm.nih.gov/pubmed/32216806 http://dx.doi.org/10.1186/s13045-020-00857-7 |
Ejemplares similares
-
Retraction Note: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression
por: Song, Huajie, et al.
Publicado: (2023) -
circ-hnRNPU inhibits NONO-mediated c-Myc transactivation and mRNA stabilization essential for glycosylation and cancer progression
por: Li, Hongjun, et al.
Publicado: (2023) -
Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression
por: Fang, Erhu, et al.
Publicado: (2020) -
Therapeutic targeting of circ‐CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression
por: Li, Huanhuan, et al.
Publicado: (2019) -
CDC20-Mediated hnRNPU Ubiquitination Regulates Chromatin Condensation and Anti-Cancer Drug Response
por: Wavelet-Vermuse, Cindy, et al.
Publicado: (2022)